Asimadoline

TargetMol
Product Code: TAR-T4633
Supplier: TargetMol
CodeSizePrice
TAR-T4633-5mg5mg£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4633-1mL1 mL * 10 mM (in DMSO)£128.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4633-25mg25mg£309.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases.
CAS:
153205-46-0
Formula:
C27H30N2O2
Molecular Weight:
414.54
Pathway:
Endocrinology/Hormones; Neuroscience; GPCR/G Protein
Purity:
0.98
SMILES:
CN([C@H](CN1CC[C@@H](C1)O)C2=CC=CC=C2)C(=O)C(C3=CC=CC=C3)C4=CC=CC=C4
Target:
Opioid Receptor

References

Camilleri, m. (2008). Novel pharmacology: asimadoline, a ?-opioid agonist, and visceral sensation.?Neurogastroenterology & Motility,?20(9), 971-979. doi: 10.1111/j.1365-2982.2008.01183.x